LC
RXDX

Lindbrook Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Lindbrook Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12
Closed -$1.29K – 2915
2023
Q1 		$1.29K Sell
12
-24
-67% -$2.58K ﹤0.01% 2402
2022
Q4 		$3.96K Buy
36
+13
+57% +$1.43K ﹤0.01% 1938
2022
Q3 		$1K Buy
+23
New +$1K ﹤0.01% 2575